Rayonier agrees to sell its New Zealand joint venture stake for $710 million
Rayonier's subsidiaries agreed on March 9, 2025 to sell their entire 77% interest in the New Zealand joint venture to a vehicle formed by Ents LP, an investment fund managed by The Rohatyn Group, for $710 million, subject to adjustments. Rayonier says the sale is modestly accretive to pro forma CAD per share and lowers pro forma net debt to Adjusted EBITDA to about 0.3x, but the filing's pro forma table also shows Adjusted EBITDA falling from $298.8 million to $245.1 million. Closing is expected in 2025, subject to regulatory approvals.
Key points
- Purchase price of $710 million for the 77% interest, implying an enterprise value of $922 million for the joint venture
- Company expects the sale to be modestly accretive to pro forma CAD per share, with a 1.3% accretion in its pro forma table
- Pro forma Adjusted EBITDA is shown at $245.1 million, versus $298.8 million in 2024 before the sale
- Closing requires approvals including antitrust in China and South Korea; either party may terminate if not closed by December 9, 2025
The filing
Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 10, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.